IDENT: Audrey Schuetz, M.D.
Audrey Schuetz, M.D., discusses Mayo Clinic Laboratories' PCR assay that identifies two recently described staphylococcus species: Staphylococcus argenteus and Staphylococcus schweitzeri. Both species are genetically related to Staphylococcus aureus, one
Episode 106 of the Answers from the Lab podcast, hosted by Mayo Clinic Laboratories, titled "IDENT: Audrey Schuetz, M.D." was published on November 9, 2021 and runs 8 minutes.
November 9, 2021 ·8m · Answers from the Lab
Summary
Audrey Schuetz, M.D., discusses Mayo Clinic Laboratories' PCR assay that identifies two recently described staphylococcus species: Staphylococcus argenteus and Staphylococcus schweitzeri. Both species are genetically related to Staphylococcus aureus, one of the most important bacteria that cause disease in humans. Short of whole-genome sequencing, Mayo Clinic Laboratories’ molecular real-time PCR assay is the only way to adequately differentiate among these staphylococcus species. Correct identification can clarify laboratory reports and guide clinicians' treatment decisions.
Episode Description
(00:32):
Today, we will be discussing staphylococcal testing at Mayo Clinic Laboratories. Before we start, Dr. Schuetz, could you please provide our listeners with a little bit about you and your background?
(01:02):
As we get started on this initiative, can you provide a brief overview of this testing and its intended use?
(02:36):
Could you describe for us which patients should have this testing and when it should be performed — including how this new testing improves upon previous testing approaches?
(04:47):
What makes our testing unique?
(05:45):
How are the results from this PCR testing used in patient care?
Similar Episodes
Apr 10, 2026 ·8m
Apr 8, 2026 ·11m
Apr 7, 2026 ·9m
Apr 6, 2026 ·8m
Apr 4, 2026 ·59m
Apr 3, 2026 ·8m